cancer science institute of singapore

Asia’s Scientific Trailblazers: Ashok Venkitaraman

Having discovered BRCA2’s crucial role in genome stability, Professor Ashok Venkitaraman continues to drive research into cancer detection and treatment at the Cancer Science Institute of Singapore and A*STAR.

A Peptide That Protects Against Liver Cancer

Scientists in Singapore have developed a peptide drug that interferes with a molecular interaction that drives liver cancer progression.

A Potential Biomarker For Aggressive Brain Cancer

Researchers have found that the levels of a protein called BCL6 can be used to identify patients with glioblastoma multiforme, a particularly aggressive type of brain cancer.

RNA Editing Gone Awry Could Indicate Gastric Cancer

Proteins involved in RNA editing could potentially be used as biomarkers to detect gastric cancer at an early stage, a study finds.

An Alternative Strategy For Treating Leukemia

Researchers have discovered that the GCN5 enzyme plays a key role in disrupting healthy white blood cell formation.

Helping Bone Marrow Cells Keep Their ‘Stemness’

Researchers have discovered a protein that helps to regulate blood stem cells in bone marrow, shedding light on the underlying causes of blood diseases.

Potential Target For TGF-β-Driven Cancers Found

The finding that USP15 enhances the stability of TGF-β signaling suggests that targeting USP15 could help treat cancers with TGF-β hyperactivation.

How HPV Hijacks Proteins To Cause Cervical Cancer

Human papilloma viruses use a protein known as EDD1 to destabilize the body's tumor suppressing mechanisms, scientists say.

Neo Mei Lin & Ling Xing Yi Awarded 2015 L’Oréal Singapore National Fellowships

Drs. Neo Mei Lin and Ling Xing Yi have been recognized for their contributions to marine biodiversity and materials science respectively.

The Genes Behind Colorectal Cancer Relapse

Researchers are developing a diagnostic test for metasizing colon cancer based on the patient's genetic profile.